Search Results

Findings Reported on Fenestrated EVAR Procedures Using Aortica's Case Planning Software

September 25, 2017—Aortica Corporation announced that Benjamin Starnes, MD, reported successful results for the first 30 patients undergoing fenestrated endovascular aneurysm repair (FEVAR) procedures that were planned and performed using Aortica’s AortaFit automated case planning software.

First Simplified FEVAR Procedure Completed With Aortica's AortaFit and Bolton's TREO Systems

November 14, 2016–Aortica Corporation announced today that Benjamin Starnes, MD, Chief of Vascular Surgery at University of Washington, completed the first three-vessel fenestrated endovascular aneurysm repair (FEVAR) using Aortica’s AortaFit investigational automated case planning software and Bolton Medical’s TREO abdominal stent graft system.

FDA Approves Use of Medtronic's Valiant Navion in Study of Aortica's Case-Planning Technology

December 17, 2018—Aortica Corporation announced that the FDA has approved a supplement to an ongoing physician-sponsored investigational device exemption study at the University of Washington.

First-in-Man Cases With Aortica's AortaFit System Support Simplified FEVAR

February 11, 2016—Aortica Corporation announced the successful completion of the first two cases using their AortaFit system to support simplified fenestrated endovascular aneurysm repair (FEVAR).

Results Published From IDE Study of Aortica's AortaFit Automated Case Planning Software

October 22, 2018—Aortica Corporation announced the publication of study results demonstrating the successful use of the company's investigational AortaFit automated case planning software to simplify the planning of the treatment and the delivery of fenestrated endovascular aneurysm repair endografts for complex abdominal aortic aneurysm (AAA) disease.

Enrollment Begins in Trial of Bolton Medical's RelayPro for Treatment of Blunt Traumatic Aortic Injury

December 5, 2017—Bolton Medical, Inc. announced that the first patient has been enrolled in the US Food and Drug Administration phase 2 clinical trial of the company's RelayPro in treating blunt traumatic aortic injury.

Terumo Acquires Aortica Corporation to Further Bolster Its Vascular Graft Portfolio

November 20, 2019—Terumo Corporation announced the acquisition of Aortica Corporation, which developed the AortaFit automated case planning software to match fenestrations on an endograft with unique locations for each of a patient's branch arteries during fenestrated endovascular aneurysm repair (FEVAR) cases.

Terumo Aortic’s Fenestrated TREO Pivotal IDE Study Begins in the United States

November 19, 2025—Terumo Aortic announced enrollment of the first patient in the fenestrated TREO pivotal trial in the United States.

LEOPARD to Compare Endologix AFX System to Other Commercially Available EVAR Devices

September 29, 2014—Endologix, Inc. announced that it will conduct a prospective, randomized clinical trial to compare outcomes in endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs). The company says the LEOPARD trial (Looking at EVAR Outcomes by Primary Analysis of Randomized Data) has been designed to provide an unbiased assessment of commercially available EVAR devices.

Endovascular Repair of Blunt Aortic Injury

Blunt aortic injury (BAI) occurs in approximately 0.3% of all trauma patients who survive to emergency department presentation and is the second leading cause of trauma-related deaths, with an estimated 8,000 deaths per year.